MiMedx Group, Inc Share Price

MiMedx Group, Inc Share Price

NASDAQ: MDXG | Small Cap
$3.89
-$0.10 (-2.63%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MiMedx Group, Inc Stock Performance

Open
$3.97
Prev. Close
$4.00
Circuit Range
N/A
Day Range
$3.79 - $3.98
Year Range
$3.05 - $7.96
Volume
1,21,678
Average Traded
$3.87

MiMedx Group, Inc Share Price Today

As of 31 October 2026, MiMedx Group, Inc's share price is $3.89. The stock opened at $3.97, compared to its previous close of $4.00. During today's trading session, MiMedx Group, Inc's share price traded between $3.79 and $3.98, with an average price of $3.88. Over the past 52 weeks, the stock has recorded a high of $7.96 and a low of $3.05. In terms of performance, MiMedx Group, Inc's share price has risen by 15.60% over the last six months and is down 49.08% on a year-on-year basis.

MiMedx Group, Inc Share Price Chart

Line chart of the MiMedx Group, Inc price trend over the selected period. The price fell overall, ranging from 3.79 to 3.98, ending at 3.90.
$3.79$3.98
L
Show Current Price
H

MiMedx Group, Inc Stock Fundamentals & Key Indicators

Market Cap
$574.92M
PE Ratio (TTM)
N/A
Dividend Yield
0.28%
EPS (TTM)
$-0.13
Revenue (TTM)
$418.63B
Return On Equity (TTM)
-9.09%
Profit Margin
11.60%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-157.14%

MiMedx Group, Inc Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$118.10$58.99$64.36$62.28
Net Profit$15.19-$10.86-$14.84-$8.68
Net Profit Margin12.86%-18.41%-23.06%-13.94%
Income ChangeN/A-171.49%-36.65%41.51%

MiMedx Group, Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$267.84$321.48$348.88$418.63
Net Profit-$30.20$58.23$42.42$48.58
Net Profit Margin-11.28%18.11%12.16%11.60%
Income ChangeN/A292.81%-27.15%14.52%

About MiMedx Group, Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

MiMedx Group, Inc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.67
$3.90
-16.33%
Sep 2026
$4.56
$4.66
+2.99%
Aug 2026
$4.32
$4.52
+9.31%
Jul 2026
$3.92
$4.13
+7.40%
Jun 2026
$3.61
$3.85
+4.34%
May 2026
$3.48
$3.69
+9.66%
Apr 2026
$3.99
$3.37
-14.81%
Mar 2026
$4.75
$3.95
-19.39%
Feb 2026
$5.09
$4.90
-4.30%
Jan 2026
$6.71
$5.12
-24.32%
Dec 2025
$6.87
$6.76
-1.60%
Nov 2025
$7.56
$6.88
-10.01%

MDXG Share Price FAQs